LGM
CEREW

Logos Global Management’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

Logos Global Management’s Portfolio CEREW Stock Details CEREW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-33,333
Closed -$144K – 72
2021
Q1 		$144K Hold
33,333
– – 0.01% 53
2020
Q4 		$188K Buy
+33,333
New +$134K 0.02% 59

Other funds holding CEREW

HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Logos Global Management's CEREW Position: Q2 2021 in Review

Logos Global Management sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q2 2021, closing a stake of 33,333 shares — an estimated $144K sold.

Logos Global Management first reported a position in CEREW in Q4 2020 and held it in 2 quarters. The position peaked at $188K in Q4 2020. 22 funds tracked by Wall St. Rank hold CEREW as of Q2 2021.

  • Logos Global Management reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q2 2021 after selling out during the quarter.
  • Logos Global Management sold 33,333 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q2 2021, an estimated $144K.
  • Logos Global Management first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q4 2020 and held it in 2 quarters.
  • Logos Global Management's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $188K in Q4 2020.
  • 22 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q2 2021.

Based on Logos Global Management's 13F filing for Q2 2021, filed 16 Aug 2021.